Resistance mutations of hepatitis B virus in entecavir‐refractory patients

The emergence of resistance mutations in the reverse transcriptase gene of hepatitis B virus (HBV) is associated with treatment failure. Entecavir (ETV) is one of the most potent anti‐HBV reagents; it has a very low resistance rate and is used as the first‐line treatment for chronic hepatitis B. In...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatol Commun
Autors principals: Yamada, Norie, Sugiyama, Ryuichi, Nitta, Sayuri, Murayama, Asako, Kobayashi, Minoru, Okuse, Chiaki, Suzuki, Michihiro, Yasuda, Kiyomi, Yotsuyanagi, Hiroshi, Moriya, Kyoji, Koike, Kazuhiko, Wakita, Takaji, Kato, Takanobu
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721430/
https://ncbi.nlm.nih.gov/pubmed/29404449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars